Altimmune Inc (NASDAQ:ALT) currently has a daily average trading volume of 2.54M but it saw 1530929 shares traded in last market. With a market cap of 445.61M USD, the company’s current market price of $6.27 came falling about -0.32 while comparing to the previous closing price of $6.29. In past 52 weeks, the stock remained buoying in the range of price level as high as $14.84 and as low as $2.09. In the recent trading on the day, stock has struck highest price mark of $6.09 while lowest mark touched by it was $6.31.
Taking a look at 20-day trading activity of Altimmune Inc (ALT) gives us an average price of $6.97, while its current price level is -57.75% below from 52-week high level whereas it is 200.00% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $6.66 while that of 200 days or SMA-200 reads an average of $8.13. A closer look into the stock’s movement over the week reveals that its volatility is standing at 7.13% during that period while stretching the period over a month that increases to 7.34%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 40.57 which implies that the stock is in neutral territory.
Goldman also issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $20 and $6.
Over the week, ALT’s stock price is moving -10.43% down while it is -1.72% when we observe its performance for the past one month. Year-to-date it is -44.27% down and over the past year, the stock is showing an upside performance of 146.85%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of -0.39 beat the consensus estimate of -0.42 for the same. The company is expected to be releasing its next quarterly report on 2024-Nov-05, for which analysts forecasted an EPS of -0.35 while estimate for next year EPS is -1.38.
Currently, Altimmune Inc’s total number of outstanding shares is 70.68M. Company’s return on investment (ROI) stands at -65.79% and return on equity (ROE) at -63.29%. Stock’s beta reads 0.08. Stock has a price to book (P/B) ratio of 2.92 while price to sale or P/S ratio amounts to 1086.85. Its return on asset (ROA) is -56.83% on average.
